Resmed Inc: (NYSE: RMD)

$50.76

0.68 (1.36%)

Volume 72,881

May 22 10:30 AM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Cash flow Statements

Get Cash flow Statements for:

Annual Cash Flow Statement

Fiscal Year End for RESMED INC falls in the month of June.

All data in Millions except Per Share data.

Cash Flow From Operations, Investments & Financial Activities

06/30/12 06/30/11 06/30/10 06/30/09 06/30/08
Cash Flow From Operations, Investments & Financial
Activities		          
Net Income (Loss) 254.85 226.98 190.08 146.44 110.30
Depreciation/Amortization & Depletion 85.85 70.61 61.56 53.96 59.48
Net Change from Assets/Liabilities 45.99 -23.51 -79.48 23.12 -64.87
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities -3.53 9.10 16.04 15.34 32.92
Net Cash From Operating Activities 383.15 283.19 188.21 238.87 137.83
Property & Equipment -47.13 -66.60 -56.85 -107.92 -52.30
Acquisition/ Disposition of Subsidiaries -53.32 -22.45 -10.20 0.61 -0.85
Investments -4.29 1.52 -0.67 -4.70 14.95
Other Investing Activities 3.13 11.02 9.42 2.72 0.35
Net Cash from Investing Activities -101.61 -76.51 -58.31 -109.29 -37.85

Uses of Funds

06/30/12 06/30/11 06/30/10 06/30/09 06/30/08
Cash Flow From Operations, Investments & Financial
Activities		          
Net Income (Loss) 254.85 226.98 190.08 146.44 110.30
Depreciation/Amortization & Depletion 85.85 70.61 61.56 53.96 59.48
Net Change from Assets/Liabilities 45.99 -23.51 -79.48 23.12 -64.87
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities -3.53 9.10 16.04 15.34 32.92
Net Cash From Operating Activities 383.15 283.19 188.21 238.87 137.83
Property & Equipment -47.13 -66.60 -56.85 -107.92 -52.30
Acquisition/ Disposition of Subsidiaries -53.32 -22.45 -10.20 0.61 -0.85
Investments -4.29 1.52 -0.67 -4.70 14.95
Other Investing Activities 3.13 11.02 9.42 2.72 0.35
Net Cash from Investing Activities -101.61 -76.51 -58.31 -109.29 -37.85
Issuance (Repurchase) of Capital Stock -330.25 -68.69 -35.86 -43.70 -74.93
Issuance (Repayment) of Debt 144.39 -25.16 -38.43 41.70 0.00
Increase (Decrease) Short-Term Debt 0.00 0.00 0.00 0.00 7.36
Payment of Dividends & Other Distributions 0.00 0.00 0.00 0.00 0.00
Other Financing Activities 8.74 14.51 13.16 3.87 3.81
Net Cash from Financing Activities -177.10 -79.34 -61.12 1.87 -63.75
Effect of Exchange Rate Changes -30.16 119.15 4.35 -36.87 27.06
Net Change In Cash & Equivalents 74.27 246.49 73.12 94.57 63.28
Cash at Beginning of Period 735.26 488.77 415.65 321.07 257.79
Cash at End of Period 809.54 735.26 488.77 415.65 321.07
Diluted Net EPS 1.71 1.44 1.23 0.95 0.70
Quick Links

Services

My Account

Resources

Client Support

Follow Us

Facebook

Twitter

Linkedin

RSS

You Tube

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.

Copyright 2013 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.